Dr. Annemarie Uliasz, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 73 Spring St, Suite 601, New York, NY 10012 Phone: 212-431-4749 Fax: 917-210-4316 |
Brendan Camp, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 820 2nd Ave Rm 3a, New York, NY 10017 Phone: 212-661-3376 |
Dr. Alexis Leibel Granite, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 32 Ericsson Place, Tribeca Park Dermatology, New York, NY 10013 Phone: 212-374-9750 Fax: 212-374-9705 |
Marissa Heller, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 560 1st Ave, Department Of Dermatology, Nyu Hospital, New York, NY 10016 Phone: 212-263-5245 |
Dr. Stephen D. Prystowsky, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 462 1st Ave # A-560, New York, NY 10016 Phone: 212-562-2300 Fax: 212-562-3486 |
Andreas Boker, M.D Dermatology - Procedural Dermatology Medicare: Accepting Medicare Assignments Practice Location: 75 Spring St Fl 2, New York, NY 10012 Phone: 212-431-4749 |
Elen Blochin, MD Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 235 E 38th St, New York, NY 10016 Phone: 212-599-2596 Fax: 212-599-4554 |
Dr. Emily Caroline Milam, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 240 E 38th St Fl 12, New York, NY 10016 Phone: 212-263-5015 |
Alreem Al-nabti, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1305 York Ave Fl 9, New York, NY 10021 Phone: 646-962-3376 |
Nanette B Silverberg, MD Dermatology - Pediatric Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10 Union Sq E, Suite 3c, New York, NY 10003 Phone: 212-844-8800 |
Joyce Cheryl Davis, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 69 5th Avenue, Suite 1a, New York, NY 10003 Phone: 212-242-3066 Fax: 212-242-3081 |
Dr. Ian Micheal Ahearn, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: Nyu Langone Medical Center, 550 1st Ave, New York, NY 10010 Phone: 212-263-5250 |
Dr. Bradley Glodny, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 580 Park Avenue, Suite 1, New York, NY 10065 Phone: 212-752-3692 Fax: 212-838-5636 |
Lori A Brightman, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 317 East 34th Street, 11th Floor, New York, NY 10016 Phone: 212-686-7306 Fax: 212-686-7305 |
Dr. Hilary L. Reich, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 900 5th Ave, New York, NY 10021 Phone: 212-725-4555 |
Dr. Michael Jonathan Albom, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 E 70th St, 1f, New York, NY 10021 Phone: 212-517-2121 Fax: 212-517-5601 |
Dr. Gary Goldenberg, MD Dermatology Medicare: Medicare Enrolled Practice Location: 5 E 98th St Fl 5, New York, NY 10029 Phone: 212-241-9065 Fax: 212-987-1197 |
Dr. Lindsay Mcguire, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1035 5th Ave, New York, NY 10028 Phone: 212-794-3548 |
Rachel Nazarian, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 35 E 35th St Rm 208, New York, NY 10016 Phone: 212-684-5964 |
Dr. Mary L. Stevenson, MD Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 240 E 38th St, 12th Floor, New York, NY 10016 Phone: 212-263-7019 |
News Archive
American Securities LLC and Arsenal Capital Partners today announced that American Securities has partnered with management and signed a definitive agreement to acquire Royal Adhesives and Sealants, LLC, a leading producer of proprietary, high-performance adhesives and sealants, from Arsenal Capital Partners.
The results of a pioneering UK-wide clinical trial that compared treatments for patients with a common type of kidney disease has found one to be significantly more effective. The results of the study, published online in The Lancet, will be recommended to clinicians worldwide as the most effective approach to treating the condition.
Drug delivery systems have progressed from the teaspoon to time-release capsules to drug-eluting stents.
NanoViricides, Inc. reports that its anti-Dengue drug candidates demonstrated significant protection in the initial animal survival studies of Dengue virus infection. The studies were performed in the laboratory of Dr. Eva Harris, Professor of Infectious Diseases at the University of California, Berkeley.
› Verified 5 days ago